As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Europlasma announces its results for the half-year period ended 30/06/2018, which were subject to a limited review by the Board of Auditors and which were approved by the Board of Directors on October 30, 2018 .
